UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 57

Sortiert nach

Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy

Canadian Medical Association journal, 2008-08, Vol.179 (5), p.417

2008

Volltextzugriff (PDF)

Residual pulmonary embolism as a predictor for recurrence after a first unprovoked episode: Results from the REVERSE cohort study

Thrombosis research, 2018-02, Vol.162, p.104-109

2018

Volltextzugriff (PDF)

Improved survival with iron chelation therapy for red blood cell transfusion dependent lower IPSS risk MDS may be more significant in patients with a non-RARS diagnosis

Leukemia research, 2012-11, Vol.36 (11), p.1380-1386

2012

Volltextzugriff (PDF)

Supportive care and chelation therapy in MDS: are we saving lives or just lowering iron?

Hematology, 2009, Vol.2009 (1), p.664-672

2009

Volltextzugriff (PDF)

Clinical Features, Treatment, and Outcome of HIV-Associated Immune Thrombocytopenia in the HAART Era

Advances in Hematology, 2012, Vol.2012, p.910954-6

2012

Volltextzugriff (PDF)

Red Blood Cell Transfusion Independence Following the Initiation of Iron Chelation Therapy in Myelodysplastic Syndrome

Advances in Hematology, 2010, Vol.2010, p.164045-5

2010

Volltextzugriff (PDF)

Clinical progression and outcome of patients with monoclonal B-cell lymphocytosis

Leukemia & lymphoma, 2007-01, Vol.48 (6), p.1087-1091

2007

Volltextzugriff (PDF)

Aplastic anemia following administration of a tumor necrosis factor‐α inhibitor

European journal of haematology, 2003-11, Vol.71 (5), p.396-398

2003

Volltextzugriff (PDF)

Improved survival in red blood cell transfusion dependent patients with primary myelofibrosis (PMF) receiving iron chelation therapy

Hematological oncology, 2010-03, Vol.28 (1), p.40-48

2010

Volltextzugriff (PDF)

Improved Outcome of Human Immunodeficiency Virus-Associated Plasmablastic Lymphoma of the Oral Cavity in the Era of Highly Active Antiretroviral Therapy: A Report of Two Cases

Leukemia & lymphoma, 2004-09, Vol.45 (9), p.1881-1885

2004

Volltextzugriff (PDF)

Acute leukemia in patients sixty years of age and older: a twenty year single institution review

American journal of clinical oncology, 2009-04, Vol.32 (2), p.137-141

2009

Volltextzugriff (PDF)

A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia

Blood, 2012-02, Vol.119 (6), p.1356-1362

2012

Volltextzugriff (PDF)

A Double-Blind, Randomized Controlled Trial of the Prevention of Clinically Important Venous Thromboembolism After Isolated Lower Leg Fractures

Journal of orthopaedic trauma, 2015-05, Vol.29 (5), p.224-230

2015

Volltextzugriff (PDF)

Validation and reliability of a disease‐specific quality of life measure (the TranQol) in adults and children with thalassaemia major

British journal of haematology, 2014-02, Vol.164 (3), p.431-437

2014

Volltextzugriff (PDF)

Family history of venous thromboembolism (VTE) as a predictor for recurrent VTE in unprovoked VTE patients

Journal of thrombosis and haemostasis, 2013-01, Vol.11 (1), p.200-203

2013

Volltextzugriff (PDF)

Residual vein obstruction as a predictor for recurrent thromboembolic events after a first unprovoked episode: data from the REVERSE cohort study

Journal of thrombosis and haemostasis, 2011-06, Vol.9 (6), p.1126-1132

2011

Volltextzugriff (PDF)

Successful Tolerance of Deferasirox Following Desensitization for Significant Skin Rash

Blood, 2011-11, Vol.118 (21), p.5280-5280

2011

Volltextzugriff (PDF)

Combination hemodialysis and centrifugal therapeutic plasma exchange: 18 years of Canadian experience

Hemodialysis international, 2013-04, Vol.17 (2), p.256-265

2013

Volltextzugriff (PDF)

Combination hemodialysis and centrifugal therapeutic plasma exchange: 18 years of C anadian experience

Hemodialysis international, 2013-04, Vol.17 (2), p.256-265

2013

Volltextzugriff (PDF)

Improved Survival with Iron Chelation Therapy for Lower IPSS Risk MDS Appears to Have a Stronger Association in Patients with a Non-RARS Diagnosis

Blood, 2011-11, Vol.118 (21), p.1732-1732

2011

Volltextzugriff (PDF)

Functional analysis of three recombinant A1-VWF domain mutants in comparison to wild type and plasma-derived VWF facilitates subtyping in type 2 von Willebrand disease

Thrombosis research, 2011-02, Vol.127 (2), p.161-166

2011

Volltextzugriff (PDF)

A randomised comparison of melphalan with prednisone or dexamethasone as induction therapy and dexamethasone or observation as maintenance therapy in multiple myeloma: NCIC CTG MY.7

British journal of haematology, 2007-01, Vol.136 (2), p.203-211

2007

Volltextzugriff (PDF)

Iron overload in myelodysplastic syndromes: A Canadian consensus guideline

Leukemia research, 2008-09, Vol.32 (9), p.1338-1353

2008

Volltextzugriff (PDF)

Identification of a Novel Coagulation Factor X Compound Heterozygous Mutation Associated with Differential Initiating Clotting Pathway Function

Blood, 2010-11, Vol.116 (21), p.1129-1129

2010

Volltextzugriff (PDF)

Functional Characterization of Three VWF- A1 Domain Mutations Causing Type 2 Von Willebrand Disease

Blood, 2009-11, Vol.114 (22), p.1305-1305

2009

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(54)

Publikationsform

Artikel
(55)
Berichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(25)
Life Sciences & Biomedicine
(25)
Science & Technology
(25)
Female
(20)
Hematology
(18)
Male
(17)
Middle Aged
(17)
Adult
(14)
Aged
(14)
Biological And Medical Sciences
(10)
Medical Sciences
(10)
Adolescent
(9)
Aged, 80 And Over
(9)
Treatment Outcome
(8)
Oncology
(6)
Retrospective Studies
(6)
Cardiovascular System & Cardiology
(5)
Hematologic And Hematopoietic Diseases
(5)
Human Health And Pathology
(5)
Life Sciences
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy

Residual pulmonary embolism as a predictor for recurrence after a first unprovoked episode: Results from the REVERSE cohort study

Improved survival with iron chelation therapy for red blood cell transfusion dependent lower IPSS risk MDS may be more significant in patients with a non-RARS diagnosis

Supportive care and chelation therapy in MDS: are we saving lives or just lowering iron?

Clinical Features, Treatment, and Outcome of HIV-Associated Immune Thrombocytopenia in the HAART Era

Red Blood Cell Transfusion Independence Following the Initiation of Iron Chelation Therapy in Myelodysplastic Syndrome

Clinical progression and outcome of patients with monoclonal B-cell lymphocytosis

Aplastic anemia following administration of a tumor necrosis factor‐α inhibitor

Improved survival in red blood cell transfusion dependent patients with primary myelofibrosis (PMF) receiving iron chelation therapy

Improved Outcome of Human Immunodeficiency Virus-Associated Plasmablastic Lymphoma of the Oral Cavity in the Era of Highly Active Antiretroviral Therapy: A Report of Two Cases

Acute leukemia in patients sixty years of age and older: a twenty year single institution review

A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia

A Double-Blind, Randomized Controlled Trial of the Prevention of Clinically Important Venous Thromboembolism After Isolated Lower Leg Fractures

Validation and reliability of a disease‐specific quality of life measure (the TranQol) in adults and children with thalassaemia major

Family history of venous thromboembolism (VTE) as a predictor for recurrent VTE in unprovoked VTE patients

Residual vein obstruction as a predictor for recurrent thromboembolic events after a first unprovoked episode: data from the REVERSE cohort study

Successful Tolerance of Deferasirox Following Desensitization for Significant Skin Rash

Combination hemodialysis and centrifugal therapeutic plasma exchange: 18 years of Canadian experience

Combination hemodialysis and centrifugal therapeutic plasma exchange: 18 years of C anadian experience

Improved Survival with Iron Chelation Therapy for Lower IPSS Risk MDS Appears to Have a Stronger Association in Patients with a Non-RARS Diagnosis

Functional analysis of three recombinant A1-VWF domain mutants in comparison to wild type and plasma-derived VWF facilitates subtyping in type 2 von Willebrand disease

A randomised comparison of melphalan with prednisone or dexamethasone as induction therapy and dexamethasone or observation as maintenance therapy in multiple myeloma: NCIC CTG MY.7

Iron overload in myelodysplastic syndromes: A Canadian consensus guideline

Identification of a Novel Coagulation Factor X Compound Heterozygous Mutation Associated with Differential Initiating Clotting Pathway Function

Functional Characterization of Three VWF- A1 Domain Mutations Causing Type 2 Von Willebrand Disease

Suchergebnisse filtern